# A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease

> **NCT02452723** · PHASE1 · COMPLETED · sponsor: **Cyto Therapeutics Pty Limited** · enrollment: 12 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **BIOLOGICAL:** ISC-hpNSC

## Key facts

- **NCT ID:** NCT02452723
- **Lead sponsor:** Cyto Therapeutics Pty Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2025-06-18
- **Final completion:** 2025-09-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02452723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02452723, "A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT02452723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*